BAVARIAN NORDICBAVARIAN NORDICBAVARIAN NORDIC

BAVARIAN NORDIC

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
0.38EUR
Revenue estimate
‪147.31 M‬EUR
Market capitalization
‪1.63 B‬EUR
‪197.84 M‬EUR
‪946.46 M‬EUR
‪77.68 M‬
Beta (1Y)
0.88

About BAVARIAN NORDIC A/S

CEO
Paul Chaplin
Headquarters
Hellerup
Employees (FY)
‪1.38 K‬
Founded
1992
ISIN
DK0015998017
FIGI
BBG00LJSB7H5
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on TRADEGATE exchange BAVARIAN NORDIC stocks are traded under the ticker BV3.
BAVARIAN NORDIC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
BV3 earnings for the last quarter are −0.59 EUR per share, whereas the estimation was 0.78 EUR resulting in a −175.00% surprise. The estimated earnings for the next quarter are 1.22 EUR per share. See more details about BAVARIAN NORDIC earnings.
BAVARIAN NORDIC revenue for the last quarter amounts to ‪184.11 M‬ EUR despite the estimated figure of ‪237.60 M‬ EUR. In the next quarter revenue is expected to reach ‪316.29 M‬ EUR.
Yes, you can track BAVARIAN NORDIC financials in yearly and quarterly reports right on TradingView.
BV3 net income for the last quarter is ‪120.89 M‬ EUR, while the quarter before that showed ‪−45.57 M‬ EUR of net income which accounts for 365.30% change. Track more BAVARIAN NORDIC financial stats to get the full picture.
No, BV3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BV3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAVARIAN NORDIC stock right from TradingView charts — choose your broker and connect to your account.
BV3 reached its all-time high on Aug 4, 2022 with the price of 56.440 EUR, and its all-time low was 14.070 EUR and was reached on Apr 1, 2020. View more price dynamics on BV3 chart.
See other stocks reaching their highest and lowest prices.
As of May 5, 2024, the company has ‪1.38 K‬ employees. See our rating of the largest employees — is BAVARIAN NORDIC on this list?
We've gathered analysts' opinions on BAVARIAN NORDIC future price: according to them, BV3 price has a max estimate of 46.19 EUR and a min estimate of 22.76 EUR. Watch BV3 chart and read a more detailed BAVARIAN NORDIC stock forecast: see what analysts think of BAVARIAN NORDIC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAVARIAN NORDIC EBITDA is ‪275.11 M‬ EUR, and current EBITDA margin is 29.07%. See more stats in BAVARIAN NORDIC financial statements.